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The spatial proximity on the surface of troponin C for sites specific for peptides CN4 (res. 96-l 16) and 
CN5 (res. 1-21) of troponin I has been demonstrated by proton magnetic resonance spectroscopy. The 
broadened signals from each peptide are at similar radial distances from the paramagnetic spin label bound 
to Cys 98 of troponin C. A U-shaped disposition of peptide CN5 about Cys 98 is indicated, the interaction 
‘+ being modulated by calcium binding to the low affinity Ca domains of troponin C. Paramagnetic 
broadening of signals from peptide CN4 was observed on addition of peptide TR2 (res. 88-159) from spin- 
labelled troponin C, a region that contains the higher affinity Ca2+ domains. 
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1. INTRODUCTION 
Some form of protein rearrangement or confor- 
mational change propagated via the troponin com- 
plex is generally held to be an integral part of the 
molecular switch for contractile activity of skeletal 
muscle initiated by calcium binding to troponin C 
[l, 21. A description of the mechanism of relay of 
the configurational effects of calcium binding re- 
quires identification of the surfaces of contact be- 
tween the interacting regulatory proteins. Affinity 
chromatographic [3] and high resolution proton 
magnetic resonance (PMR) studies [4] on peptides 
of troponin I have identified two regions of the 
primary sequence of the protein to be involved in 
interaction with troponin C. We report here on an 
extension of these PMR studies which 
demonstrates: 
(9 The specificity and the calcium sensitivity of 
each of the two regions of troponin I 
represented by residues 1-21 and residues 
96-116 for troponin C; 
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(ii)The relative spatial disposition of the two 
troponin I-troponin C interaction sites on the 
topography of troponin C. 
2. MATERIALS AND METHODS 
Rabbit skeletal troponin C and troponin I were 
purified from whole troponin as in [5]. Peptides of 
troponin I were prepared by cyanogen bromide 
cleavage of [14C]carboxymethylated troponin I [3, 
41 and were characterized by amino acid analysis. 
Troponin C was labelled at Cys 98 using 3-iodo- 
acetamido-2,2,5,5_tetramethyl- 1 -pyrrolidinyloxyl 
(obtained from Syva, Palo Alto CA). 
PMR spectra were recorded at 300 MHz on a 
Bruker instrument operating in the Fourier 
transform mode. An inter-pulse overall delay of 2 
s was used to allow full relaxation. Titrations of 
the two CNBr peptides of troponin I, peptide CN4 
(residues 96-l 16) and peptide CN5 (residues 
l-21), with spin-labelled troponin C or its spin- 
labelled C-terminal tryptic fragment, TR2, were 
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Fig. 1. Sequences and proton magnetic resonance spectra of the two cyanogen bromide fragments of troponin I, peptide 
CN5 (top) and peptide CN4 (bottom). The arrows indicate the residue sidechains influenced by binding to troponin C [4]. 
carried out by addition of aliquots of stock solu- 
tions and led to negligible dilution of the troponin 
I peptides. The extent of calcium bound to 
troponin C or TR2 was altered by addition of small 
aliquots (1-5 ~1) of 2 mM EGTA, the pH being 
maintained constant using 0.1 M NaO*H. All pH 
values quoted are uncorrected for isotope effects. 
3. RESULTS AND DISCUSSION 
Complex formation between troponin C, and 
peptides CN4 and CN5 of troponin I in the 
presence of calcium has been demonstrated to in- 
volve particular residue sidechains of each peptide 
through the specific PMR spectral perturbations 
induced upon titration with troponin C [4] (see fig. 
1). To investigate the architecture of the com- 
plexes, titrations of each peptide with spin-labelled 
troponin C were carried out. Spatial proximity 
(5 15 A [8]) of any peptide sidechain to the 
paramagnetic spin label covalently bound to Cys 
98 of troponin C would be reflected in enhanced 
relaxation (broadening) of the corresponding 
sidechain signal, the relaxation effects induced 
varying as r+ from the bound probe. Thus obser- 
vation of paramagnetic-induced broadening of 
peptide signals would not only confirm the occur- 
rence of complex formation ([4] and fig. 1) but 
also, through any differential broadening effects 
on the various sidechain resonances, enable in the 
first instance a qualitative description of the 
disposition of each peptide relative to the probe 
bound to Cys 98 of troponin C. 
Addition of spin-labelled troponin C to a solu- 
tion of peptide CN5, residues 1-21, led to marked 
paramagnetic broadening of specific resonances 
(fig. 2). Notably and differentially broadened were 
the signals deriving from the ,&CH3 groups of Ala9 
and Ala12, the 7-CH3 of threonine 11, the 6-CH3 
of arginine and the aromatic signals of His 16. 
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Fig. 2. Relaxation (broadening) effects of particular sidechain groups of peptide CN5 (residues 1-21) induced by binding 
of troponin C spin-labelled at Cys 98 in the presence of calcium: (A) peptide CN5, 5 x 10 -4 M, pH 8.0; (B) peptide 
CN5 after addition of spin-labelled troponin C; molar peptide/protein ratio 25:1; (C) difference spectrum (a-b) showing 
the specific groups whose resonances are broadened due to proximity to the paramagnetic spin label. 
Relatively unperturbed by the spin label were the 
signals from sidechains of lysine, glutamate and 
the N-acetyl end group (fig. 2). These sidechains 
are located at the extremities of the peptide se- 
quence. Thus extending the data in fig 1, these pro- 
be experiments indicate a U-shaped disposition of 
the complexed peptide CN5 about the bound probe 
on Cys 98 of troponin C. Reduction in the amount 
of calcium bound to troponin C was achieved by 
back titration with EGTA and resulted in an in- 
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Fig. 3. Calcium sensitivity to the spectral perturbation of
a mixture of peptide CN4 and peptide CN5 due to in- 
teraction with spin-labelled troponin C: (A) resonances 
of Phe 100 and 106 of peptide CN4 alone (5 x 10m4 M); 
(B) broadened signals of Phe 100 and 106 at a molar 
ratio of peptide CN4 to spin-labelled troponin C of 25: 1; 
(C) broadened signals of Phe 100 and 106 (peptide CN4) 
and His 16 (peptide CNS) upon addition of peptide CN5 
in equimolar amounts to peptide CN4; (D) loss of 
paramagnetic relaxation of the signals of His 16, upon 
back titration with 2 mM EGTA; the signals of Phe 100 
and 106 (peptide CN4) remain unperturbed. 
crease in intensity of the paramagnetically relaxed 
signals (fig. 2); i.e., a modulation of complex for- 
mation by calcium binding. 
In order to determine the specificity of each of 
the two peptides for sites on troponin C, peptide 
CN4 (residues 96-l 16) was added to a mixture of 
peptide CN5 and spin-labelled troponin C in the 
presence of calcium. Consistent with the data ob- 
tained upon complex formation of peptide CN4 
with spin-labelled troponin C (not shown), and 
with the data in fig. 1, addition of peptide CN4 to 
the mixture resulted in specific paramagnetic- 
induced broadening of signals distinct to peptide 
CN4 (e.g., Phe 100 and 106, fig. 3). No further 
change in paramagnetic broadening due to the spin 
label on Cys 98 of troponin C was observed for 
signals distinct to peptide CN5 (e.g., His 16, fig. 
3). Thus both peptides were complexed without 
competition indicating site specificity. This conclu- 
sion is supported from consideration of the relative 
concentrations of peptides to spin-labelled protein 
‘doped’ in solution (fig. 3). Further, the com- 
parative relaxation effects on the signals of His 16 
and Phe 100 and 106 indicate that both peptides 
are disposed at distinct sites both at a similar radial 
distance (r) from the spin-label probe on Cys 98 of 
troponin C. 
Evidence for individual reactive sites for each 
peptide on the surface of troponin C comes also 
from the differential calcium sensitivity of binding 
of the two peptides. Back titration with EGTA to 
reduce the amount of calcium bound to troponin 
C led first to the loss of paramagnetic broadening 
of signals of peptide CN5 (e.g., His 16, fig.3) with 
no observable alteration in the paramagnetic 
broadening of the signals from residues Phe 100 
and Phe 106 of peptide CN4. These observations 
indicate that complex formation between the N- 
terminal segment of troponin I, represented by 
peptide CNS, and troponin C is modulated by 
calcium binding to the lower affinity domains I 
and II in the N-terminal half of troponin C. 
In an effort to ascertain the individual locations 
of the two interactive sites on troponin C, titra- 
tions of peptides CN4 and CN5 were separately 
carried out using the tryptic fragment peptide TR2 
of troponin C previously spin-labelled at Cys 98. 
This fragment, residues 88-159, comprises the two 
higher affinity sites of troponin C [9]. Consistent 
with the data described above no paramagnetic 
broadening effects were observed upon titration 
into a solution of peptide CN5 up to a 3:l ratio of 
peptide CN5 to peptide TR2. Marked relaxation of 
signals from Phe 100 and Phe 106 was however 
readily observable during a separate titration with 
peptide CN4. Competition between the two 
troponin I peptides was not observed. 
Taken overall, these data enable a schematic 
representation of the interaction between the two 
troponin subunits (fig. 4) indicating the spatial 
proximity on the surface of troponin C of two 
reactive sites for troponin I whose interaction with 
troponin I is differentially modulated by calcium 
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Fig. 4. Schematic representation of the topography of 
the troponin C-troponin I complex. 
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terminal site. This could involve modulation of the 
troponin C-troponin I interaction that occurs on 
the segment of troponin I interacting with actin 
(i.e., residues 96-l 16). Experiments in progress by 
both PMR and ESR spectroscopy using other 
paramagnetic probes support this suggestion. 
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